chr11-64307201-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004451.5(ESRRA):āc.22A>Cā(p.Ile8Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000194 in 1,596,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004451.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ESRRA | NM_004451.5 | c.22A>C | p.Ile8Leu | missense_variant | 2/7 | ENST00000000442.11 | NP_004442.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ESRRA | ENST00000000442.11 | c.22A>C | p.Ile8Leu | missense_variant | 2/7 | 1 | NM_004451.5 | ENSP00000000442 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000918 AC: 22AN: 239720Hom.: 0 AF XY: 0.0000613 AC XY: 8AN XY: 130494
GnomAD4 exome AF: 0.0000180 AC: 26AN: 1443892Hom.: 0 Cov.: 31 AF XY: 0.0000126 AC XY: 9AN XY: 715406
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | The c.22A>C (p.I8L) alteration is located in exon 2 (coding exon 1) of the ESRRA gene. This alteration results from a A to C substitution at nucleotide position 22, causing the isoleucine (I) at amino acid position 8 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at